Pfizer

US President Donald Trump near a sign on lowering drug prices in the Oval Office of the White House in Washington, DC, US.
Law

Pfizer strikes $70B deal with Trump to cut Medicaid drug prices, expand American manufacturing under tariff threat

By Tom Murphy, Michelle S. Price and The Associated Press
September 30, 2025
Google Ventures CEO David Krane speaks at Fortune Brainstorm Tech on September 9th, 2025, in Park City, Utah.
Success

CEO says his son is among Gen Zers questioning whether a college degree is worth it: ‘Is this education a scam?’

By
September 17, 2025
Pfizer (PFE) Q2 2025 Earnings Call Transcript

Pfizer (PFE) Q2 2025 Earnings Call Transcript

By
August 5, 2025
Businessman contemplating in a financial district
Leadership

Summer Fridays are dead because remote work killed them

By
July 3, 2025
Ireland sees thousands of jobs at risk from U.S. pharma tariffs
Workplace Culture

Ireland sees thousands of jobs at risk from U.S. pharma tariffs

By Olivia Fletcher, Stephen Carroll and Bloomberg
June 23, 2025
Court rejects European Commission’s refusal to share texts between von der Leyen and Pfizer CEO during COVID pandemic
Politics

Court rejects European Commission’s refusal to share texts between von der Leyen and Pfizer CEO during COVID pandemic

By Sam McNeil and The Associated Press
May 15, 2025
Pfizer (PFE) Q1 2025 Earnings Call Transcript

Pfizer (PFE) Q1 2025 Earnings Call Transcript

By
April 29, 2025
Brainstorm Health 2021-Pfizer-Albert Bourla
Newsletters

Pfizer CEO Albert Bourla sees ‘a scientific renaissance’ in the U.S. amid backdrop of political threats to the future of research

By
April 24, 2025
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
Commentary

The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

By Jeffrey Sonnenfeld and Steven Tian
February 5, 2025
Albert Bourla, chief executive officer of Pfizer Inc., during a panel session at the World Economic Forum
Health

Pfizer CEO had dinner with RFK Jr.: ‘I’m cautiously optimistic’ in spite of his history with vaccines

By
February 4, 2025
Row of medical vials and syringe
Health

Pfizer’s Covid boost overshadowed by Kennedy threat to vaccines

By Bloomberg and Damian Garde
February 4, 2025
Pfizer (PFE) Q4 2024 Earnings Call Transcript

Pfizer (PFE) Q4 2024 Earnings Call Transcript

By
February 4, 2025
Days before President Donald Trump took office a second time, the Department of Health and Human Services granted Moderna $590 million for the development of mRNA vaccines for bird flu and other influenza viruses.
Health

As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines

By
January 23, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By
January 22, 2025
A white sign featuring the Pfizer logo
Health

GSK, Pfizer RSV shots must warn about rare paralysis risk

By
January 8, 2025

Most Popular